Study of Intratumoral IVX037 in Patients With Advanced or Metastatic Solid Tumours — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Study of Intratumoral IVX037 in Patients With Advanced or Metastatic Solid Tumours — Stella

Recruiting

Back to Colorectal Cancer trials

Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.

Trial locations(3 sites)

Australia

Sydney site, Sydney, New South Wales

South Australia site, Adelaide, South Australia

Melbourne Site, Melbourne, Victoria

Key details

Phase

Early testing

Sponsor

ImmVirx Pty Ltd

Collaborators

Innovent Biologics (Suzhou) Co. Ltd.

Enrollment target

~70 participants

Started

February 2023

Primary completion

June 2028

Age range

18 Years – 85 Years

Last updated March 2026

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov